Leukemic stem cells and therapy resistance in acute myeloid leukemia
A major obstacle in the treatment of acute myeloid leukemia (AML) is refractory disease or relapse after achieving remission. The latter arises from a few therapy-resistant cells within minimal residual disease (MRD). Resistant cells with long-term self-renewal capacity that drive clonal outgrowth...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ferrata Storti Foundation
2023-02-01
|
| סדרה: | Haematologica |
| גישה מקוונת: | https://haematologica.org/article/view/10948 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|